[Source]
WEST CHESTER, Pa. (July 30, 2012) — Daicel has announced the appointment of Dieter Heckmann to the position of Executive Officer – Daicel Corporation. As a member of the executive leadership team within Daicel, Mr. Heckmann will assume responsibility for global operations of the Chiral Pharmaceutical Ingredients (CPI) Company, reporting to Mr. Misao Fudaba, President and CEO of Daicel Corporation. In addition to his new duties for CPI, Mr. Heckmann will retain his role as Chief Executive Officer of Chiral Technologies Europe SAS (Illkirch, France), Chiral Technologies Inc. (West Chester, Pa.), and Daicel Chiral Technologies (India) Pvt. Ltd. (Hyderabad).
“I am honored and excited to take on this new global role within Daicel. Chiral Technologies and CPI are poised to move ahead in developing novel chirality tools for the pharmaceutical, agrochemical and fragrance industries,” said Mr. Heckmann. We will work together to maximize the value of our current and future products and services; our shared goal is to exceed the expectations of our customers.”
About Chiral Technologies Worldwide
Chiral Technologies Worldwide, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Chiral Technologies Worldwide serves the North and Latin American markets through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com, www.chiral.fr, and www.daicelchiraltech.cn.